Directions in Discovery and Development

//Directions in Discovery and Development

Directions in Discovery and Development

Pharmaceutical, biotechnology, food, environmental, and chemical companies are all challenged by the same expectations when they partner with a laboratory to do their bioanalytical, analytical, and environmental testing: depth and breadth of expertise, scope of services, accuracy and speed of results and reporting, quality, efficiency and regulatory knowledge of the staff. Our customers, be they pharma/biotech Sponsors or industrial clients, expect these attributes from their bioanalytical and analytical testing partner, and the Laboratory Sciences Division at MPI Research stands ready to provide them.

How to Assess Preclinical Dose Formulation Homogeneity
Homogeneity or uniformity of a dose formulation is a requirement for ensuring integrity of regulated preclinical safety studies. Demonstrating homogeneity ensures that the preclinical dose formulation.
Read more…


 

Meeting Challenges for Analysis of Antibody Drug Conjugates
Chemotherapy is a mainstay of a standardized treatment regimen for cancer. However, the nonspecific targeting of healthy cells as well as tumor cells by cytotoxic small molecule drugs often.
Read more… 


 

Preclinical Dose Formulation Stability
Establishing adequate stability of a preclinical dose formulation is a critical component in drug development, as it ensures that the test system receives the appropriate amount of test article based on protocol specifications.
Read more…  


 

Determining Potency of Preclinical Dose Formulations
Potency is a required measurement to determine the amount of active ingredient contained in a preclinical dose formulation.
Read more… 


 

Validation of a Bioanalytical ICP-MS Method for Quantification of Potassium in Human Urine
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) is being increasingly utilized to quantify the concentration of elements in biomatrices in support of nonclinical and clinical studies.
Read more…  


 

Drug Development: Why do we make it so hard?
In today’s world of drug development almost every aspect of the development continuum is related to speed, efficiency, precision, and quality.
Read more… 


 

By | 2017-07-04T10:28:27+00:00 April 29th, 2013|News|Comments Off on Directions in Discovery and Development

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.